Testing for disorders of calcium metabolism

Area of Science:

• Clinical chemistry
• Endocrinology
• Bone metabolism

Background:

• Serum hormone assays are crucial for diagnosing various endocrine and metabolic disorders.
• Parathyroid hormone, calcitonin, and vitamin D play vital roles in calcium homeostasis and bone health.
• Accurate measurement of these biomarkers aids in clinical decision-making.

Purpose of the Study:

• To review the clinical utility of serum immunoreactive parathyroid hormone (PTH) assays.
• To highlight the importance of serum calcitonin measurements in medullary carcinoma diagnosis.
• To discuss the role of serum 25-hydroxyvitamin D and dihydroxylated vitamin D metabolites in patient management.

Main Methods:

• Review of clinical applications of serum hormone assays.
• Discussion of diagnostic and monitoring roles of specific biomarkers.
• Analysis of the relevance of vitamin D metabolite measurements.

Main Results:

• Serum PTH assays are valuable for hypercalcemia diagnosis and assessing uremic bone disease.
• Serum calcitonin is essential for medullary thyroid carcinoma detection and metastasis surveillance.
• Serum 25-hydroxyvitamin D monitoring prevents vitamin D intoxication and suggests osteomalacia in specific patient groups.

Conclusions:

• Serum hormone assays, including PTH, calcitonin, and vitamin D metabolites, offer significant clinical value.
• These assays are indispensable for diagnosing endocrine disorders, monitoring treatment, and preventing complications.
• Further research may enhance the clinical relevance of dihydroxylated vitamin D metabolite measurements.